Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Immune Checkpoint Inhibitors × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 20 Carcinoma, Hepatocellular 11 Neoplasms 7 Melanoma 7 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Colonic Neoplasms 5 Nasopharyngeal Carcinoma 4 Colorectal Neoplasms 4 Small Cell Lung Carcinoma 3 Recurrence 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Solid Cancers 2 Skin Neoplasms 2 Prostatic Neoplasms 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Gastric / Gastroesophageal Junction Adenocarcinoma 2 Esophageal Squamous Cell Carcinoma 2 EBV-associated Tumors 2 Breast Neoplasms 2 Bites and Stings 2

Interventions

Cyclophosphamide 46 fludarabine 29 Rituximab 28 Doxorubicin 13 Prednisone 12 Magnetic Resonance Spectroscopy 12 fludarabine phosphate 11 Vincristine 11 Specimen Handling 11 Bendamustine Hydrochloride 10 pirtobrutinib 9 Lenalidomide 9 Etoposide 9 Biopsy 8 pembrolizumab 7 obinutuzumab 7 zanubrutinib 6 venetoclax 6 polatuzumab vedotin 5 glofitamab 5 Leukapheresis 5 Immunotherapy, Adoptive 5 tazemetostat 4 tafasitamab 4 ibrutinib 4 etoposide phosphate 4 Nivolumab 4 Injections 4 CT-P10 4 loncastuximab tesirine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡